GW Pharmaceuticals plc
Overview
GW Pharmaceuticals plc, a subsidiary of Jazz Pharmaceuticals Plc, is a leading biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform. It is renowned for its expertise in cannabinoid science and medicines, particularly for neurological conditions.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to GW Pharmaceuticals plc in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.